Ftse Mib
38.472,56
0,13%
DAX
22.425,93
0,73%
S&P 500
5.983,25
-0,50%
NASDAQ
19.286,92
-1,21%
Bitcoin
92.027,11
0,64%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Capricor Therapeutics Inc (CAPR) Capricor Therapeutics Inc (CAPR) Notizie

Capricor Therapeutics Inc

CAPR
14,3201
-0,6799 (-4,53%)
25 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/2/202515:00GLOBECapricor Therapeutics to Participate in Upcoming Investor..
05/2/202523:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/1/202501:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202501:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202501:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202501:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202501:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202501:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202501:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202501:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202501:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202501:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202501:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202520:17EDGAR2Form 8-K - Current report
02/1/202515:15GLOBECapricor Therapeutics Completes Submission of Biologics..
16/12/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202422:15GLOBECapricor Therapeutics to Present at Upcoming Investor..
20/11/202415:00GLOBECapricor Therapeutics Granted Orphan Drug and ATMP Status..
14/11/202422:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202422:02EDGAR2Form 8-K - Current report
13/11/202422:01GLOBECapricor Therapeutics Reports Third Quarter 2024 Financial..
12/11/202417:46EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
12/11/202415:00GLOBECapricor Therapeutics to Present Exosome Platform Updates at..
12/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
05/11/202415:00GLOBECapricor Therapeutics to Present Third Quarter 2024..
22/10/202423:11EDGAR2Form S-3 - Registration statement under Securities Act of..
18/10/202422:01GLOBECapricor Therapeutics Announces Closing of Underwritten..
17/10/202422:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/10/202412:01EDGAR2Form 8-K - Current report
17/10/202412:00GLOBECapricor Therapeutics Announces Pricing of Approximately $75..
16/10/202422:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/10/202422:25EDGAR2Form 8-K - Current report
16/10/202422:17GLOBECapricor Therapeutics Announces Proposed Public Offering of..
16/10/202419:31EDGAR2Form S-3/A - Registration statement under Securities Act of..
11/10/202415:15GLOBECapricor Therapeutics Announces Positive Long-Term Data from..
09/10/202415:16EDGAR2Form 8-K - Current report
09/10/202415:15GLOBECapricor Therapeutics Announces Initiation of Rolling..
04/10/202415:15GLOBECapricor Therapeutics to Present Long-Term Data from HOPE-2..
24/9/202422:03EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
24/9/202422:01EDGAR2Form 8-K - Current report
24/9/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/9/202414:00GLOBECapricor Therapeutics Announces Intent to File Biologics..
23/9/202415:25GLOBECapricor Therapeutics to Provide Duchenne Muscular Dystrophy..
17/9/202415:15EDGAR2Form 8-K - Current report
17/9/202415:15GLOBECapricor Therapeutics Signs Binding Term Sheet with Nippon..
06/9/202414:30GLOBECapricor Therapeutics to Present at Upcoming Investor and..
23/8/202422:01EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
09/8/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 15,00 Min: 13,66 Max: 15,19
Chiusura: 15,00

La tua Cronologia

NASDAQ
CAPR
Capricor Therapeutics
TSXV
IMI
International Millennium...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci